FDA Approves Moderna, J&J Booster Shots, Backs Mix ‘n’ Match Vaccines
Agency’s decision is one of the last steps toward a full rollout of booster shots to eligible Americans
General Medicine
FDA Expected to Allow Mix ‘n’ Match COVID-19 Vaccines
Agency will not recommend one vaccine over another but may say it is preferable to use same booster as the vaccine
Therapeutic-Dose LMWH Cuts Thromboembolism, Deaths in COVID-19
Reduction in venous thromboembolism, arterial thromboembolism, and deaths seen in high-risk patients in non-ICU, but not ICU, settings
Acute Myocarditis Rare After COVID-19 mRNA Vaccination in Adults
Incidence of myocarditis 5.8 cases per 1 million adults after the second dose; safety signal for increased myocarditis seen in young men
Study Characterizes Multisystem Inflammatory Syndrome in Adults
Review shows median age of 21 years, involvement of 5 organ systems, and presentation 4 weeks after COVID-19
US Passes 700,000 COVID-19 Deaths
Most of the last 100,000 Americans to die from the disease did so in a period where vaccines were widely available
7000 Steps Per Day Tied to Lower Risk for Early Death
No association seen between step intensity in middle age and later mortality
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
Exactly who qualifies as high risk because of health or work reasons is not yet clear
COVID-19 Has Killed More Americans Than the Spanish Flu Did in 1918
This happened despite vast gains in scientific knowledge during the past century
Interim Data Show No Increase in Serious Outcomes Post-COVID-19 Vaccination
Incidence of ischemic stroke, appendicitis, or acute myocardial infarction not increased 1 to 21 days after mRNA COVID-19 vaccination
- Loading...
Loading...
Next post in Men's Health Update
Loading... 
Loading...